A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s00280-017-3274-0
Published Online: 2017-03-14
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kondo, Naru
Murakami, Yoshiaki
Uemura, Kenichiro
Sudo, Takeshi
Hashimoto, Yasushi
Nakagawa, Naoya
Takahashi, Shinya
Ohge, Hiroki
Sueda, Taijiro
License valid from 2017-03-14